A study by Yale School of Medicine reveals that survival rates for patients with a thoracic aneurysm are significantly better, and complications are fewer, among patients who take statin cholesterol drugs than those who do not. The study appears in the American Journal of Cardiology.
- Mechanical Engineering - Aug 20 The power of salt
- Microtechnics - Aug 19 Why this U of’T biotech entrepreneur made MIT’s Innovators Under 35 list
- Pedagogy - Aug 19 How parents juggle work hours may influence kids' weight
- Mechanical Engineering - Aug 19 Wong named one of world's top Innovators Under 35 by MIT Technology Review
- Medicine - Aug 19 Mother whose young daughter died from ovarian cancer raises money for UCLA cancer research
- Social Sciences - Aug 19 Hungry workers feel more entitled, research suggests
- Event - Aug 19 Poetry's evolutionary niche at Cornell Plantations
- Medicine - Aug 19 Heart disease and strokes have dropped in the U.S. in last decade
- Administration - Aug 19 Congressional staffers learn about cybersecurity at Stanford boot camp
- Environmental Sciences - Aug 19 A gentle reminder – and guidelines – from Stanford Recycling
- Literature - Aug 19 Stanford scholar sees failure as key element of success for famous American authors
Statins may protect against death from aneurysm, Yale study finds
An aneurysm is a swelling of an artery, and is a common cause of death. It’s usually asymptomatic, with death or a life-threatening complication such as rupture or dissection being the first manifestation. Statins are cholesterol-lowering drugs that are widely used in patients with cardiovascular disease.
Assistant professor of cardiothoracic surgery Ion S. Jovin, M.D., and colleagues studied 649 patients with thoracic aortic aneurysms: 147 were taking statins and 502 were not. In long-term follow-up 80% of those taking statins survived, compared with 67% percent of those not taking statins. In addition, a smaller percentage of those taking statins suffered a rupture or dissection (splitting of the aorta), compared to those who were not taking statins.
"The intake of statins was associated with an improvement in long-term outcomes among these patients," said co-author John Elefteriades, M.D., professor of cardiothoracic surgery at Yale School of Medicine and director of the Aortic Institute at Yale-New Haven Hospital. "In addition to better survival, fewer patients taking statins required surgical intervention," Elefteriades added.
Medical science has searched for decades for a medicine that could treat aneurysm disease, with little success. The current standard therapy is to keep blood pressure low to discourage rupture of the enlarged artery. Jovin said his research suggests that "statins could offer a significant protective effect to patients at risk of death or complications from aneurysm disease. However, the ultimate proof would be a randomized clinical trial." Elefteriades adds, "We now have some arrows in our quiver of medicines to treat this disease."
Other authors are Mona Duggal, Keita Ebisu, Hyung Paek, A. Dana Oprea, Maryann Tranquilli, John Rizzo, Redin Memet, Marina Feldman, James Dziura, and Cynthia A. Brandt of Yale.
Last job offers
- Medicine - 20.8
- Business - 20.8
Assistant or Associate Professor
- Medicine - 20.8
Clinical Assistant Professor / JACSW
- Chemistry - 20.8
Assistant Professor---Bio-Organic / Chemical Biology- Chemistry
- Chemistry - 20.8
Assistant Professor - Physical-- Chemistry
- Life Sciences - 19.8
Microbiology - Assistant Professor (AA7671)
- Literature - 19.8
- Philosophy - 19.8
Assistant / Associate Professor